Rijal Keshab, Maraia Richard J
Intramural Research Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States of America.
PLoS Genet. 2016 Aug 12;12(8):e1006253. doi: 10.1371/journal.pgen.1006253. eCollection 2016 Aug.
The ability of RNA polymerase (RNAP) III to efficiently recycle from termination to reinitiation is critical for abundant tRNA production during cellular proliferation, development and cancer. Yet understanding of the unique termination mechanisms used by RNAP III is incomplete, as is its link to high transcription output. We used two tRNA-mediated suppression systems to screen for Rpc1 mutants with gain- and loss- of termination phenotypes in S. pombe. 122 point mutation mutants were mapped to a recently solved 3.9 Å structure of yeast RNAP III elongation complex (EC); they cluster in the active center bridge helix and trigger loop, as well as the pore and funnel, the latter of which indicate involvement of the RNA cleavage domain of the C11 subunit in termination. Purified RNAP III from a readthrough (RT) mutant exhibits increased elongation rate. The data strongly support a kinetic coupling model in which elongation rate is inversely related to termination efficiency. The mutants exhibit good correlations of terminator RT in vitro and in vivo, and surprisingly, amounts of transcription in vivo. Because assessing in vivo transcription can be confounded by various parameters, we used a tRNA reporter with a processing defect and a strong terminator. By ruling out differences in RNA decay rates, the data indicate that mutants with the RT phenotype synthesize more RNA than wild type cells, and than can be accounted for by their increased elongation rate. Finally, increased activity by the mutants appears unrelated to the RNAP III repressor, Maf1. The results show that the mobile elements of the RNAP III active center, including C11, are key determinants of termination, and that some of the mutations activate RNAP III for overall transcription. Similar mutations in spontaneous cancer suggest this as an unforeseen mechanism of RNAP III activation in disease.
RNA聚合酶(RNAP)III从终止阶段有效循环至重新起始的能力,对于细胞增殖、发育及癌症过程中丰富的tRNA产生至关重要。然而,对于RNAP III所采用的独特终止机制的理解并不完整,其与高转录输出的联系也不明确。我们利用两种tRNA介导的抑制系统,在粟酒裂殖酵母中筛选具有终止表型获得和缺失的Rpc1突变体。122个点突变体被定位到最近解析的酵母RNAP III延伸复合物(EC)的3.9 Å结构上;它们聚集在活性中心桥螺旋和触发环,以及孔道和漏斗区域,后者表明C11亚基的RNA切割结构域参与了终止过程。从通读(RT)突变体中纯化的RNAP III表现出提高的延伸速率。这些数据有力地支持了一种动力学偶联模型,即延伸速率与终止效率呈负相关。这些突变体在体外和体内的终止子RT以及令人惊讶的体内转录量之间表现出良好的相关性。由于评估体内转录可能会受到各种参数的干扰,我们使用了一个具有加工缺陷和强终止子的tRNA报告基因。通过排除RNA降解速率的差异,数据表明具有RT表型的突变体比野生型细胞合成更多的RNA,且合成量超过了其增加的延伸速率所能解释的范围。最后,突变体增加的活性似乎与RNAP III阻遏物Maf1无关。结果表明,包括C11在内的RNAP III活性中心的可移动元件是终止的关键决定因素,并且一些突变激活了RNAP III的整体转录。自发癌症中的类似突变表明这是疾病中RNAP III激活的一种意外机制。